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    To investigate the prevalence of methicillin and aminoglycoside resistance and gene encoding 
staphylococcal cassette chromosome mec (SCCmec) and aminoglycoside modifying enzymes in clinical 
isolates of coagulase negative staphylococci(CoNS) from hospitalized patients. One hundred and three isolates 
of coagulase negative staphylococci(CoNS) were recovered from various clinical samples from August 2013 to 
November 2014. All the specimens were identified by conventional microbiological methods. These tests were 
contained colony morphology, gram stain, catalase, slide and tube coagulase. To determine the sensibility of 
CoNS to antimicrobial components including Cefoxitin(30µg), Tobramycin(10µg), Kanamycin(30µg), 
Amikacin(30µg) and Gentamicin(10µg), disk diffusion method was performed by Kirby Bauer antibiotic 
testing. In order to show the presence of  methicillin and aminoglycoside resistant CoNS genes, PCR were 
demonstrated. In our study the rate of resistance to Cefoxitin, Kanamycin, Gentamicin, Tobramycin and 
Amikacin were 74(71.8%), 54(52,4%), 51(49.5%), 45(43.7%) and 16(15.5%), respectively. Some strains of 
CoNS have been detected with intermediate resistance to Kanamycin 4(3.9%), Tobramycin and Amikacin 
2(1.9%). In our study, the distribution of mecA gene among clinical isolates of CoNS was 89(86.4%). The 
prevalence of aminoglycoside resistance genes like ant(4 ')-Ia, aac(6 ')/aph(2 ") and aph(3 ')-IIIa were 
89(86.4%), 87(84.5%) and 68(66%), respectively. The rate of coexistence of aac(6’)-Ie-aph(2’’) with aph(3’)-
IIIa and aac(6’)-Ie-aph(2’’) with ant(4’)-Ia was 65(63%) and 77(74%), respectively. Resistance to 
aminoglycosides, develops quickly in coagulase-negative staphylococci from clinical areas where these 
antimicrobial agents are widely used. Therefore, higher investments should be directed towards identifying 
coagulase-negative staphylococcus species in healthcare institutions and in the community. Overall, Knowing 
the epidemiology and antibiotic resistance of CoNS is essential to implement the prevention strategies and 
reducing antibiotic consumptions. 
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INTRODUCTION 
    Coagulase negative staphylococcus as a 
microbial flora which is associated with 
nosocomial infection due to its connection with 
medical devices[1]. CoNS can become involved in 
infection such as heart valves, pacemaker lines and 
boxes, cerebrospinal shunts, and prosthetic joints. 
People at high risk for developing infections were 
considered to be low birth weight infants, and 
individuals who are immunocompromised by 
diseases such as cancer and the chemotherapy and 
dialysis patients[1-3]. 
High-level resistance to methicillin is caused by 
the mecA gene, which encodes an alternative 
penicillin-binding protein, PBP 2a (PBP2’), located 
at the staphylococcal cassette chromosome mec 
(SCCmec). Although eighth types of SCCmec(I-
VIII) have been recognized between staphylococci,  
types IV and V are currently found in 
Staphylococcus epidermidis and Staphylococcus 
haemolyticus[4, 5]. It has been 
supposed that SCCmec can be transferred between 
staphylococci like coagulase negative 
staphylococcus(MRCoNS)[6]. 
Many anti-staphylococcal therapies inhibit protein 
biosynthesis like aminoglycosides  which play an 
important role in perish of  bacteria[7, 8]. The main 
mechanism of aminoglycoside resistance is drug 
 




inactivation by cellular aminoglycoside-modifying 
enzymes. Modifying enzymes have been encoded 





phosphoryltransferase III [APH(3’)-III] [9, 10]. 
Aminoglycosides modified at amino groups by 
AAC enzymes or at hydroxyl groups by ANT or 
APH enzymes, lose their ribosome-binding ability 
and inhibit protein synthesis[11]. The bifunctional 
enzyme, AAC(6’)/APH(2’’), is encoded on 
composite transposon Tn4001,  mediates  
resistance to gentamicin and concomitant 
resistance to tobramycin and kanamycin in 
coagulase negative staphylococcus[11]. ANT(4’)-I 
, is often carried on small plasmids, and then 
integrated into larger conjugative plasmids, such as 
pSK41, and subsequently into the mec region of 
the chromosome of some S. aureus isolates, 
mediates resistance to neomycin, kanamycin, 
tobramycin and amikacin in staphylococci[11]. 
According to APH(3’)-III enzyme can mediate 
resistance to neomycin and kanamycin, it may be 
located on both the chromosome and plasmids[12]. 
In an attempt to determine the prevalence of 
methicillin and aminoglycoside resistance and gene 
encoding staphylococcal cassette chromosome mec 
(SCCmec) and aminoglycoside modifying 
enzymes in clinical isolates of coagulase negative 
staphylococci(CoNS) from hospitalized patients. 
 
MATERIALS AND METHODS 
Bacterial strains 
    From August 2013 to November 2014, 103 
coagulase negative staphylococcus that were 
isolated from males 58(56.3%) and female 
45(43.7%) were recovered from clinical samples 
including blood, wound, pus, urine, Central 
nervous system, catheter, sputum, 
 bronchoalveolar, prosthetic joints and fluid 
body from hospitalized patients in Taleghani, 
Mofid, khatam, Motahari, Sasan and Pars 
hospitals, Tehran, Iran. The isolates were 
identified by their phenotypic characteristic like 
colony morphology, gram stain, catalase, slide 
and tube coagulase. 
 
Identification and susceptibility testing 
    All isolates were tested, using a disc diffusion 
method, for resistance to Gentamicin(10µg), 
Tobramycin(10µg), Kanamycin(30µg), 
Amikacin(30µg) and Cefoxitin(30µg) 
(MAST, Merseyside. U.K) according to the 
guidelines provided by the CLSI[13].  
 
DNA Extraction and Amplification 
    Total DNA template was extracted by 
Kit(Qiagen N.V.). The primers used for PCR 
amplification are presented in table one. The 
PCR reactions were carried out in Intellectica 
thermo cycler by using the PCR Master Kit 
(Cinna Clone Inc., Iran) according to the 
manufacturer guideline. PCR condition was as 
follows: Initial denaturation at 95°C for 5 
minutes followed by 30 cycles of denaturation at 
95°C for 1 minute, annealing for mecA gene 1 
minute at 57°C,aac(6’)/aph(2’’) 45 second at 
56°C,  ant(4’)-I 30 second at 48°C  and aph(3’)-
III 45 second at 57.5°C , extension at 72°C for 
30 second.  
The final extension step was continued for 
another mecA gene 8 minutes at 72°C and the 
rest of aminoglycoside gene 1 minutes at 72°C. 
DNA fragments were analyzed by 
electrophoresis in a 1% agarose gel at 95 V for 




    Statistical analysis was performed using SPSS 
software for Windows, version 17.0 (SPSS Inc., 
Chicago, IL) and Chi-squared test. 
 
Table1. PCR primers used to detect aminoglycoside resistance genes in this study 
gene Amplicon size(bp) Primer (5'      3') 
mecA 310 
GTA GAA ATG ACT GAA CGT CCG ATA A  
















A total of 103 strains of coagulase negative 
staphylococcus(blood=27, wound=37, pus=1, 
urine=15, CNS=2, catheter=4, sputum=9, 
 bronchoalveolar=2, prosthetic joints=1 and fluid 
body=5) were recovered from six hospitals of 
Tehran, Iran. The rates of resistance to different 
antibiotic are shown in Table 2. 
 
Table 2. Antimicrobial susceptibilities of 103 coagulase-negative staphylococci isolates to 6 antibiotic in  
Hospital  Antibiotics No.(%)  
Tobramycin Kanamycin Amikacin Gentamicin Cefoxitin 
K 17(65.4) 20(76.9) 20(76.9) 20(76.9) 25(96.2) 
M 7(30.4) 7(30.4) 1(4.3) 8(34.8) 12(52.2) 
P 8(33.3) 9(37.5) 4(16.7) 8(33.3) 18(75) 
MO 6(46.2) 8(61.5) 2(15.4) 7(53.8) 9(69.2) 
S 1(11.1) 3(33.3) 0 2(22.2) 3(33.3) 
T 6(75) 7(87.5) 3(37.5) 6(75) 7(87.5) 
Total 45(43.5) 54(54.5) 30(25.1) 51(49.3) 74(68.9) 
K= Khatam, M= Motahari, P= Pars, MO= Mofid, S=Sasan and T= Taleghani 




Figure 1. Antimicrobial susceptibility testing CoNS isolates 
 
According to table 1, the rate of resistance to 
kanamycin, Gentamicin, Tobramycin and 
Amikacin were 54.5% , 49,3%, 43.5% and 25.1%, 
respectively. Also, regarding to table 2, the 
proportion of MRCNS which showed resistance 
to the aminoglycosides in this study, was higher 
than that of the MSCNS isolates. There was no 
significant difference between aminoglycoside 
and their sites of isolation. since more than half of 
the isolates carrying mec A gene, the relationship 
between methicillin and aminoglycoside 
resistance was noticeable (table 2). The most 
prevalence of aminoglycoside resistance genes 
amongst isolates of coagulase negative 
staphylococcus was ant(4’)-I, occurring in 87.6% 
of MRCNS. However, The rate of 
aac(6’)/aph(2’’) was pretty great. The least 
common was aph(3’)-III, found in 66.3% of 
MRCNS. The rate of coexistence of aac(6’)-Ie-
aph(2’’) with aph(3’)-IIIa and aac(6’)-Ie-aph(2’’) 











Table 3. The distribution of aminoglycoside resistance in isolates of coagulase-negative staphylococci (CNS) in relation to 
methicillin resistance and sites of infection 
sites of isolation Tobramycin Kanamycin Amikacin Gentamicin 
MSCNS  
wound 0 1(6.3) 0 1(6.3) 
Blood 2(40) 4(80) 1(20) 3(60) 
urine 1(25) 1(25) 0 1(25) 
sputum 2(100) 2(100) 1(50) 1(50) 
Fluid body 1(50) 1(50) 1(50) 1(50) 
catheter 0 1(100) 0 1(100) 
Total 6(35.8) 10(60.2) 3(20) 8(48.5) 
MRCNS  
wound 13(36.1) 13(36.1) 3(8.3) 13(36.1) 
Blood 15(68.2) 16(72.7) 8(36.4) 15(68.2) 
urine 4(26.7) 5(33.3) 2(13.3) 6(40) 
sputum 5(71.4) 7(100) 2(28.6) 6(85.7) 
Fluid body 0 1(25) 0 0 
catheter 2(66.7) 1(33.3) 0 1(33.3) 
BAL 2(100) 2(100) 2(100) 2(100) 
CNS 1(50) 1(50) 1(50) 1(50) 
prosthetic joints 1(100) 1(100) 1(100) 1(100) 
pus 1(100) 1(100) 1(100) 1(100) 
Total 44(68.7) 48(65) 20(54.5) 46(68.1) 
 
Table 4. The distribution of aminoglycoside resistance genes in isolates of coagulase negative staphylococci (CNS) in 
relation to methicillin resistance 




aac(6’)/aph(2’’) 13(92.9) 74(83.1) 
aph(3’)-III 9(64.3) 59(66.3) 
ant(4’)-I 11(78.9) 78(87.6) 
Abbreviations: MSCNS, methicillin susceptible CNS; MRCNS, methicillin-resistant CNS 
 
 
Figure 2. Detection of genes encoding mec A gene in 
coagulase negative staphylococci by PCR. M, 100 pb 
DNA ladder (Fermentas); lane 1, positive control; lane 2, 
negative control; lane 3 and 5 patient samples  
 
Figure 3. Detection of genes encoding ant(4’)-I gene in 
coagulase negative staphylococci by PCR. M, 100 pb 
DNA ladder (Fermentas); lane 1, positive control; lane 5, 
negative control; lane 2-4 patient samples  
 





Figure 3. Detection of genes encoding aac(6’)-
aph(2’’)gene in coagulase negative staphylococci by 
PCR. M, 100 pb DNA ladder (Fermentas); lane 1, 




Figure 4. Detection of genes encoding aph(3’)-III in 
coagulase negative staphylococci by PCR. M, 100 pb 
DNA ladder (Fermentas); lane 1, positive control; lane 2, 
negative control; lane 3 and 4 patient samples
DISCUSSION 
    Excessive consume of different antibiotic is 
caused to emerge multi-drug resistance in 
developing countries[14]. Aminoglycosides have 
been an important group of antibiotics in treatment 
of serious bacterial infections, especially gram 
negative bacteria, but current reports indicated the 
emergence of resistance to aminoglycosides in 
Coagulase negative staphylococcus isolates in 
different parts of the world[15]. The goal of this 
study was to investigate the prevalence of 
methicillin and aminoglycoside resistance and gene 
encoding staphylococcal cassette chromosome mec 
(SCCmec) and aminoglycoside modifying 
enzymes in clinical isolates of coagulase negative 
staphylococci(CoNS) from hospitalized patients. 
The methicillin resistance rate of 86%(89/103)  
among our CoNS isolates was approximately 13% 
higher than those reported among Colombia, Brazil 
and Egyptian medical centers[16-18]. In the 
current study, despite many studies which had 
shown the rate of aac(6’)/aph(2’’) gene was more 
common than other ones[19-21], In this study the 
most prevalence of aminoglycoside resistance 
genes  between our isolates was ant(4’)-I (87.6%) 
that this result was similar to reports from Kuwait 
and Japan[22, 23]. 
 The second most prevalent AMEs gene was 
aac(6’)-Ie-aph(2’’), this gene enables to 
inactivate gentamicin, kanamycin, tobramycin, 
neomycin, and amikacin[24]. The third one was 
aph(3)-IIIa. Although this gene, which causes to 
inactivate kanamycin and amikacin[24], was the 
lowest in our article, its amount was higher than 
the study had been done in different studies[20, 
25]. 
We detected the probable coexistence of all 
three enzymes in vast majority of our isolates, as 
did two researchers in their study[23]. According 
to the existence of two mecA and AMEs genes, 
some studies have shown, there is a correlation 
between aminoglycoside and methicillin 
resistance that leading to spread of multi drug 
resistant (MDR) isolates [19, 23, 25]. 
High level of resistance among CNS isolates and 
spread of MDR isolates is threat for hospitalized 
patients and limits the use of antimicrobial agents 
for therapy [26].  
In conclusion, continuous surveillance should be 
directed towards identifying coagulase-negative 
staphylococcus species in healthcare institutions 
and in the community and also, prescribing 
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